Search for: "Abbott v. Abbott" Results 1281 - 1300 of 2,325
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) Omnicef (Cefdinir) – US: CAFC on whether a product-by-process claim is infringed by an identical product made by different process: Abbott Labs v Sandoz (IP Frontline) Pertussis vaccines – UK: EWHC dismisses Medeva appeal against pertussis vaccines SPCs refusal (The SPC Blog) Plavix (Clopidogrel) – Canada: Adding some obvious flexibility: Apotex Inc v Sanofi-Synthelabo Canada Inc (IP… [read post]
22 Apr 2016, 7:57 am by Amy Howe
  In The Daily Signal, Josh Siegel reports on comments by Texas governor Greg Abbott, who predicts that the Court will deadlock in the case. [read post]
25 Jan 2007, 12:24 am
Hevesi, respondent NEW YORK COUNTYPersonal PropertyUntimely Mechanic's Lien Discharged; Lien Notice Required Within Four Months in Single Dwelling Matter of Abbott v. [read post]
24 Jan 2007, 12:34 am
Hevesi, respondent NEW YORK COUNTYPersonal PropertyUntimely Mechanic's Lien Discharged; Lien Notice Required Within Four Months in Single Dwelling Matter of Abbott v. [read post]
10 Jun 2009, 5:00 am
: Abbott v Sandoz (Patent Baristas) (FDA Law Blog) (Patents4Life) Optimum GAT corn – US: BASF Plant Science files patent infringement suit against Pioneer Hi-Bred International based on its sale of Optimum GAT corn; Pioneer countersues for patent infringement and declaratory judgment of non-infringement and patent invalidity (Patent Docs) Oracea (Doxycycline) – US: Galderma submits new QI Act 30-month stay citizen petition; a new variation on an old theme (FDA… [read post]
1 Mar 2011, 8:38 pm by Marie Louise
Highlights this week included: Humira (Adalimumab) – US: $1.67B verdict overturned by CAFC, patent invalidated over written description: Centocor v Abbott (Peter Zura’s 271 Patent Blog) (Patently-O) (Patently-O) (Patent Law Practice Center) (Patent Docs) (IPBiz) Fexofenadine – Australia: Anti-histamine inventive… but not novel, says Federal Court! [read post]
10 Jun 2009, 5:00 am
: Abbott v Sandoz (Patent Baristas) (FDA Law Blog) (Patents4Life) Optimum GAT corn – US: BASF Plant Science files patent infringement suit against Pioneer Hi-Bred International based on its sale of Optimum GAT corn; Pioneer countersues for patent infringement and declaratory judgment of non-infringement and patent invalidity (Patent Docs) Oracea (Doxycycline) – US: Galderma submits new QI Act 30-month stay citizen petition; a new variation on an old theme (FDA… [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
11 Jan 2011, 11:07 pm by Kelly
Highlights this week included: US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques (Patently-O) (Patents Post Grant Blog) (PharmaPatents) (IPBiz) US: Reverse payment settlements return to the Supreme Court: Louisiana Wholesale Drug Co et al v Bayer et al (Patently-O) (FDA Law Blog) Kaletra (Ritonavir, Lopinavir) – India: Abbott’s patent on AIDS medicine denied (IP Watch) (Spicy IP) (SiNApSE) Please join the discussion by adding your comments on… [read post]
9 Oct 2015, 9:22 am by Lyle Denniston
Abbott — definition of population measure to be used in election redistricting to satisfy “one person, one vote” principle Wednesday, December 9: Fisher v. [read post]
7 Jun 2013, 11:06 am by Don Cruse
SUSAN COMBS, COMPTROLLER OF PUBLIC ACCOUNTS OF THE STATE OF TEXAS AND GREG ABBOTT, ATTORNEY GENERAL OF THE STATE OF TEXAS v. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360)   Products… [read post]
20 May 2009, 5:18 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) Omnicef (Cefdinir) - US: CAFC rules… [read post]